Establishment Labs Inc.

42.96
0.09 (0.21%)
At close: Mar 03, 2025, 3:59 PM
41.22
-4.05%
Pre-market: Mar 04, 2025, 04:07 AM EST

Company Description

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.

The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name.

It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution.

The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally.

Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Establishment Labs Inc.
Establishment Labs  Inc. logo
Country CR
IPO Date Jul 19, 2018
Industry Medical - Devices
Sector Healthcare
Employees 933
CEO Rajbir Singh Denhoy

Contact Details

Address:
Building B15 and 25
Alajuela,
CR
Website https://www.establishmentlabs.com

Stock Details

Ticker Symbol ESTA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001688757
CUSIP Number G31249108
ISIN Number VGG312491084
Employer ID 98-1436377
SIC Code 3842

Key Executives

Name Position
Rajbir Singh Denhoy Chief Financial Officer
Roberto de Mezerville Chief Technology Officer
Ivan Bilic Senior Vice President of Commercial Operations - OUS
Jeff Ehrhardt Senior Vice President & GM of North America
Neeta Toprani Corporate Secretary
Rosalyn Cole d'Incelli SVice President of Global Clinical, Medical & US Regulatory Affairs

Latest SEC Filings

Date Type Title
Feb 28, 2025 S-8 Filing
Feb 28, 2025 10-K Annual Report
Feb 26, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 14, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 13, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 11, 2025 SCHEDULE 13G/A [Amend] Filing
Jan 16, 2025 8-K Current Report
Jan 13, 2025 8-K Current Report
Jan 03, 2025 4 Filing